Affiliation:
1. Division of Hematology, Department of Medicine, and
2. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Abstract
AbstractAutoimmune hemolytic anemia (AIHA) is an uncommon entity that presents diagnostic, prognostic, and therapeutic dilemmas despite being a well-recognized entity for over 150 years. This is because of significant differences in the rates of hemolysis and associated diseases and because there is considerable clinical heterogeneity. In addition, there is a lack of clinical trials required to refine and update standardized and evidence-based therapeutic approaches. To aid the clinician in AIHA management, we present four vignettes that represent and highlight distinct clinical presentations with separate diagnostic and therapeutic pathways that we use in our clinical practice setting. We also review the parameters present in diagnostic testing that allow for prognostic insight and present algorithms for both diagnosis and treatment of the AIHA patient in diverse situations. This is done in the hope that this review may offer guidance in regard to personalized therapy recommendations. A section is included for the diagnosis of suspected AIHA with negative test results, a relatively infrequent but challenging situation, in order to assist in the overall evaluation spectrum for these patients.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference86 articles.
1. Über Beziehungen zwischen dem Blutserum und den Körperzellen;Landsteiner;Munch Med Wochenschr,1903
2. Uber paroxysmale Hamoglobinurie;Donath;Munch Med Wochenschr,1904
3. Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965;Allgood;Am J Med,1967
4. Autoimmune hemolytic anemia: a history;Mack;Transfus Med Rev,2000
5. A new test for the detection of weak and incomplete Rh agglutinins;Coombs;Br J Exp Pathol,1945
Cited by
135 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献